Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2017-10-10

EMA Application withdrawn: Tigecycline Accord (tigecycline) — Accord Healthcare Ltd

View source ↗

Summary

The EMA withdrew the application for Tigecycline Accord by Accord Healthcare Ltd for soft tissue infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tigecycline Accord (tigecycline)

Snippet

Status: Application withdrawn. Therapeutic area: Soft Tissue Infections. MAH: Accord Healthcare Ltd. Decision date: 15/09/2017